UI Hospitals and Clinics
Participants in this study have been newly diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The purpose of the study is to test the safety of the drug, ABT-888, at different dose levels. Approximately 10 women will take part in this study conducted by investigators at the University of Iowa.
Lynn Schaul, 319-384-6076
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.